Long-term care facilities are reservoirs for antimicrobial-resistant sequence type 131 Escherichia coli

Open Forum Infectious Diseases

Volumn 2, Issue 1, 2015, Pages

  Burgess, Mary J ^a   Johnson, James R ^b,c   Porter, Stephen B ^b,c   Johnston, Brian ^c   Clabots, Connie ^b   Lahr, Brian D ^d   Uhl, James R ^d   Banerjee, Ritu ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MAYO CLINIC   (United States)

Author keywords

E. coli; E. coli resistance; Long term care facilities; ST131

Indexed keywords

ADHESIN; BACTERIAL TOXIN; CD59 ANTIGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIDEROPHORE;

AGED; ANTIBIOTIC RESISTANCE GENE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CROSS-SECTIONAL STUDY; DECUBITUS; ESCHERICHIA COLI; FECES INCONTINENCE; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NURSING CARE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; URINE INCONTINENCE;

EID: 84978327774     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv011     Document Type: Article

References (38)

1. Johnson JR, Tchesnokova V, Johnston B, et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 2013; 207:919-28.
2. Banerjee R, Johnston B, Lohse C, et al. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013; 34:361-9.
3. Cohen AE, Lautenbach E, Morales KH, et al. Fluoroquinolone-resistant Escherichia coli in the long-term care setting. Am J Med 2006; 119: 958-63.
4. Colpan A, Johnston B, Porter S, et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 2013; 57:1256-65.
5. Lopez-Cerero L, Bellido Mdel M, Serrano L, et al. Escherichia coli O25b: H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance. Enferm Infecc Microbiol Clin 2013; 31: 385-8.
6. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014; 27:543-74.
7. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66:1-14.
8. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61:273-81.
9. Johnson JR, Nicolas-Chanoine MH, DebRoy C, et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012; 18:598-607.
10. Johnson JR, Porter SB, Zhanel G, et al. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 2012; 80:1554-62.
11. Clermont O, Lavollay M, Vimont S, et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008; 61:1024-8.
12. Mora A, Dahbi G, Lopez C, et al. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLoS One 2014; 9:e87025.
13. Lavigne JP, Vergunst AC, Goret L, et al. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 2012; 7:e34294.
14. Moreno E, Andreu A, Perez T, et al. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect 2006; 134:1015-23.
15. Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 2014; 58:4997-5004.
16. van der Donk CF, Schols JM, Driessen CJ, et al. Prevalence and spread of multidrug resistant Escherichia coli isolates among nursing home residents in the southern part of The Netherlands. J Am Med Dir Assoc 2013; 14:199-203.
17. Lautenbach E, Tolomeo P, Black N, et al. Risk factors for fecal colonization with multiple distinct strains of Escherichia coli among longterm care facility residents. Infect Control Hosp Epidemiol 2009; 30: 491-3.
18. Maslow JN, Lautenbach E, Glaze T, et al. Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance. Antimicrob Agents Chemother 2004; 48:3618-20.
19. Rooney PJ, O'LearyMC, Loughrey AC, et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacinresistant Escherichia coli. J Antimicrob Chemother 2009; 64:635-41.
20. Burke L, Humphreys H, Fitzgerald-Hughes D. The revolving door between hospital and community: extended-spectrum beta-lactamaseproducing Escherichia coli in Dublin. J Hosp Infect 2012; 81:192-8.
21. Nicolas-Chanoine MH, Robert J, Vigan M, et al. Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates. PLoS One 2013; 8:e72191.
22. Dhanji H, Doumith M, Rooney PJ, et al. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK. J Antimicrob Chemother 2011; 66:297-303.
23. Ribot EM, Fair MA, Gautom R, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006; 3:59-67.
24. Banerjee R, Robicsek A, Kuskowski MA, et al. Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-beta-lactamase-positive and-negative E. coli clinical isolates from the Chicago region, 2007 to 2010. Antimicrob Agents Chemother 2013; 57:6385-8.
25. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66:4555-8.
26. March A, Aschbacher R, Dhanji H, et al. Colonization of residents and staff of a long term care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect 2009; 16:934-44.
27. Lautenbach E, Han J, Santana E, et al. Colonization with extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella species in long-term care facility residents. Infect Cont Hosp Epidemiol 2012; 33:302-4.
28. Yoo J, Byeon J, Yang J, et al. High prevalence of extended-spectrum beta-lactamases and plasmid-mediate AmpC beta-lactamases in Enterobacteriaceae isolated from long term care facilities in Korea. Diag Microbiol Infect Dis 2010; 67:261-5.
29. Brisse S, Diancourt L, Laouenan C, et al. Phylogenetic distribution of CTX-M-and non-extended-spectrum-beta-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J Clin Microbiol 2012; 50:2974-81.
30. Han JH, Maslow J, Han X, et al. Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities. J Infect Dis 2014; 209:420-5.
31. Kudinha T, Johnson JR, Andrew SD, et al. Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J Clin Microbiol 2013; 51:3270-6.
32. Kudinha T, Johnson JR, Andrew SD, et al. Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers. Pediatr Infect Dis J 2013; 32:543-8.
33. Liss MA, Peterson EM, Johnston B, et al. Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology 2013; 81:548-55.
34. Olesen B, Hansen DS, Nilsson F, et al. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 2013; 51:1779-85.
35. Yamamoto S, Tsukamoto T, Terai A, et al. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol 1997; 157:1127-9.
36. Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis 2000; 31:752-6.
37. Morgan DJ, Diekema DJ, Sepkowitz K, et al. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009; 37:85-93.
38. Furuno JP, Krein S, Lansing B, et al. Health care worker opinions on use of isolation precautions in long-term care facilities. Am J Infect Control 2012; 40:263-6.